177 related articles for article (PubMed ID: 25139019)
1. Dietary pectin-derived acidic oligosaccharides improve the pulmonary bacterial clearance of Pseudomonas aeruginosa lung infection in mice by modulating intestinal microbiota and immunity.
Bernard H; Desseyn JL; Bartke N; Kleinjans L; Stahl B; Belzer C; Knol J; Gottrand F; Husson MO
J Infect Dis; 2015 Jan; 211(1):156-65. PubMed ID: 25139019
[TBL] [Abstract][Full Text] [Related]
2. Pectin-Derived Acidic Oligosaccharides Improve the Outcome of Pseudomonas aeruginosa Lung Infection in C57BL/6 Mice.
Bernard H; Desseyn JL; Gottrand F; Stahl B; Bartke N; Husson MO
PLoS One; 2015; 10(11):e0139686. PubMed ID: 26599638
[TBL] [Abstract][Full Text] [Related]
3. Cytokine and surface receptor diversity of NK cells in resistant C3H/HeN and susceptible BALB/c mice with chronic Pseudomonas aeruginosa lung infection.
Calum H; Moser C; Jensen PØ; Shirai R; Høiby N
APMIS; 2003 Sep; 111(9):891-7. PubMed ID: 14510646
[TBL] [Abstract][Full Text] [Related]
4. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
[TBL] [Abstract][Full Text] [Related]
5. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity.
Cui Z; Han D; Sun X; Zhang M; Feng X; Sun C; Gu J; Tong C; Lei L; Han W
Appl Microbiol Biotechnol; 2015 Jan; 99(2):667-80. PubMed ID: 25381907
[TBL] [Abstract][Full Text] [Related]
6. Low-dose clarithromycin therapy modulates CD4(+) T-cell responses in a mouse model of chronic Pseudomonas aeruginosa lung infection.
Ding FM; Zhu SL; Shen C; Jiang YQ
Respirology; 2012 May; 17(4):727-34. PubMed ID: 22404374
[TBL] [Abstract][Full Text] [Related]
7. Gamma Interferon and Interleukin-17A Differentially Influence the Response of Human Macrophages and Neutrophils to Pseudomonas aeruginosa Infection.
Muntaka S; Almuhanna Y; Jackson D; Singh S; Afryie-Asante A; Cámara M; Martínez-Pomares L
Infect Immun; 2019 Feb; 87(2):. PubMed ID: 30455194
[TBL] [Abstract][Full Text] [Related]
8. Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice.
Moser C; Johansen HK; Song Z; Hougen HP; Rygaard J; Høiby N
APMIS; 1997 Nov; 105(11):838-42. PubMed ID: 9393554
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis.
Hartl D; Griese M; Kappler M; Zissel G; Reinhardt D; Rebhan C; Schendel DJ; Krauss-Etschmann S
J Allergy Clin Immunol; 2006 Jan; 117(1):204-11. PubMed ID: 16387607
[TBL] [Abstract][Full Text] [Related]
10. Regulation of pulmonary Pseudomonas aeruginosa infection by the transcriptional repressor Gfi1.
Grassmé H; Jin J; Wilker B; von Kürthy G; Wick W; Weller M; Möröy T; Gulbins E
Cell Microbiol; 2006 Jul; 8(7):1096-105. PubMed ID: 16819963
[TBL] [Abstract][Full Text] [Related]
11. Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1-dominated cytokine response.
Moser C; Jensen PO; Kobayashi O; Hougen HP; Song Z; Rygaard J; Kharazmi A; H by N
Clin Exp Immunol; 2002 Feb; 127(2):206-13. PubMed ID: 11876741
[TBL] [Abstract][Full Text] [Related]
12. Signal transducer and activator of transcription 4 (STAT4), but not IL-12 contributes to Pseudomonas aeruginosa-induced lung inflammation in mice.
O'Sullivan R; Carrigan SO; Marshall JS; Lin TJ
Immunobiology; 2008; 213(6):469-79. PubMed ID: 18514749
[TBL] [Abstract][Full Text] [Related]
13. Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium.
Collie D; Glendinning L; Govan J; Wright S; Thornton E; Tennant P; Doherty C; McLachlan G
PLoS One; 2015; 10(11):e0142097. PubMed ID: 26544950
[TBL] [Abstract][Full Text] [Related]
14. The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type.
Moser C; Kjaergaard S; Pressler T; Kharazmi A; Koch C; Høiby N
APMIS; 2000 May; 108(5):329-35. PubMed ID: 10937769
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin-induced gut dysbiosis during Pseudomonas aeruginosa pulmonary infection in a mice model.
Rosa CP; Pereira JA; Cristina de Melo Santos N; Brancaglion GA; Silva EN; Tagliati CA; Novaes RD; Corsetti PP; de Almeida LA
J Leukoc Biol; 2020 Jan; 107(1):95-104. PubMed ID: 31682032
[TBL] [Abstract][Full Text] [Related]
16. Depletion of natural killer cells increases mice susceptibility in a Pseudomonas aeruginosa pneumonia model.
Broquet A; Roquilly A; Jacqueline C; Potel G; Caillon J; Asehnoune K
Crit Care Med; 2014 Jun; 42(6):e441-50. PubMed ID: 24732238
[TBL] [Abstract][Full Text] [Related]
17. Cytokine modulating effect of ginseng treatment in a mouse model of Pseudomonas aeruginosa lung infection.
Song Z; Moser C; Wu H; Faber V; Kharazmi A; Høiby N
J Cyst Fibros; 2003 Sep; 2(3):112-9. PubMed ID: 15463859
[TBL] [Abstract][Full Text] [Related]
18. The Nonantibiotic Macrolide EM703 Improves Survival in a Model of Quinolone-Treated Pseudomonas aeruginosa Airway Infection.
Kasetty G; Bhongir RKV; Papareddy P; Herwald H; Egesten A
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652240
[TBL] [Abstract][Full Text] [Related]
19. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses.
Nizri E; Irony-Tur-Sinai M; Lory O; Orr-Urtreger A; Lavi E; Brenner T
J Immunol; 2009 Nov; 183(10):6681-8. PubMed ID: 19846875
[TBL] [Abstract][Full Text] [Related]
20. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
Hazlett LD; McClellan S; Kwon B; Barrett R
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):805-10. PubMed ID: 10711697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
